CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
57
CTSH Quote, Financials, Valuation and Earnings
Last price:
$77.92
Seasonality move
:
6.24%
Day range:
$77.23 - $78.37
52-week range:
$63.79 - $90.82
Dividend yield:
1.55%
P/E ratio:
16.41x
P/S ratio:
1.93x
P/B ratio:
2.58x
Volume:
3.7M
Avg. volume:
4.1M
1-year change:
15.18%
Market cap:
$38.4B
Revenue:
$19.7B
EPS (TTM):
$4.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.7B | $18.5B | $19.4B | $19.4B | $19.7B | |
| Revenue Growth (YoY) | -0.78% | 11.14% | 4.98% | -0.39% | 1.98% | |
| Cost of Revenues | $10.7B | $11.6B | $12.4B | $12.7B | $13B | |
| Gross Profit | $6B | $6.9B | $7B | $6.7B | $6.8B | |
| Gross Profit Margin | 35.92% | 37.3% | 35.93% | 34.56% | 34.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.1B | $3.5B | $3.4B | $3.3B | $3.2B | |
| Other Inc / (Exp) | -$328M | -$20M | $8M | -$216M | -$153M | |
| Operating Expenses | $3.7B | $4.1B | $4B | $3.8B | $3.8B | |
| Operating Income | $2.3B | $2.8B | $3B | $2.9B | $3B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.1B | $2.8B | $3B | $2.8B | $2.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $704M | $693M | $730M | $668M | $713M | |
| Net Income to Company | $1.4B | $2.1B | $2.3B | $2.1B | $2.2B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.4B | $2.1B | $2.3B | $2.1B | $2.2B | |
| Basic EPS (Cont. Ops) | $2.58 | $4.06 | $4.42 | $4.21 | $4.52 | |
| Diluted EPS (Cont. Ops) | $2.57 | $4.05 | $4.41 | $4.21 | $4.51 | |
| Weighted Average Basic Share | $540M | $527M | $518M | $505M | $496M | |
| Weighted Average Diluted Share | $541M | $528M | $519M | $505M | $497M | |
| EBITDA | $2.7B | $3.4B | $3.6B | $3.4B | $3.5B | |
| EBIT | $2.1B | $2.8B | $3B | $2.8B | $3B | |
| Revenue (Reported) | $16.7B | $18.5B | $19.4B | $19.4B | $19.7B | |
| Operating Income (Reported) | $2.3B | $2.8B | $3B | $2.9B | $3B | |
| Operating Income (Adjusted) | $2.1B | $2.8B | $3B | $2.8B | $3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.8B | $4.8B | $4.8B | $5.1B | |
| Revenue Growth (YoY) | 4.17% | 9.66% | -0.29% | -1.08% | 7.46% | |
| Cost of Revenues | $2.8B | $3.1B | $3.1B | $3.1B | $3.4B | |
| Gross Profit | $1.6B | $1.7B | $1.7B | $1.6B | $1.7B | |
| Gross Profit Margin | 37.2% | 35.83% | 34.68% | 33.91% | 33.59% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $827M | $862M | $835M | $765M | $791M | |
| Other Inc / (Exp) | -$11M | $1M | $15M | -$15M | $63M | |
| Operating Expenses | $968M | $1B | $967M | $896M | $927M | |
| Operating Income | $669M | $724M | $702M | $718M | $791M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $665M | $729M | $738M | $722M | $872M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $160M | $170M | $158M | $179M | $213M | |
| Net Income to Company | $505M | $563M | $580M | $546M | $663M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $505M | $563M | $580M | $546M | $663M | |
| Basic EPS (Cont. Ops) | $0.95 | $1.07 | $1.14 | $1.10 | $1.34 | |
| Diluted EPS (Cont. Ops) | $0.95 | $1.07 | $1.14 | $1.10 | $1.34 | |
| Weighted Average Basic Share | $530M | $524M | $509M | $497M | $494M | |
| Weighted Average Diluted Share | $531M | $525M | $509M | $498M | $495M | |
| EBITDA | $808M | $874M | $879M | $866M | $1B | |
| EBIT | $667M | $731M | $747M | $733M | $884M | |
| Revenue (Reported) | $4.4B | $4.8B | $4.8B | $4.8B | $5.1B | |
| Operating Income (Reported) | $669M | $724M | $702M | $718M | $791M | |
| Operating Income (Adjusted) | $667M | $731M | $747M | $733M | $884M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.8B | $18.9B | $19.4B | $19.3B | $20.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.7B | $11.9B | $12.5B | $12.7B | $13.2B | |
| Gross Profit | $6.1B | $7B | $6.9B | $6.6B | $6.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.2B | $3.5B | $3.4B | $3.2B | $3.2B | |
| Other Inc / (Exp) | -$180M | -$8M | $22M | -$246M | -$75M | |
| Operating Expenses | $3.8B | $4.1B | $4B | $3.7B | $3.8B | |
| Operating Income | $2.4B | $2.9B | $2.9B | $2.9B | $3.1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.3B | $2.9B | $3B | $2.8B | $3.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $722M | $703M | $718M | $689M | $747M | |
| Net Income to Company | $1.5B | $2.2B | $2.3B | $2.1B | $2.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.5B | $2.2B | $2.3B | $2.1B | $2.4B | |
| Basic EPS (Cont. Ops) | $2.85 | $4.18 | $4.49 | $4.18 | $4.75 | |
| Diluted EPS (Cont. Ops) | $2.85 | $4.17 | $4.49 | $4.16 | $4.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.8B | $3.5B | $3.6B | $3.4B | $3.7B | |
| EBIT | $2.3B | $2.9B | $3.1B | $2.8B | $3.1B | |
| Revenue (Reported) | $16.8B | $18.9B | $19.4B | $19.3B | $20.1B | |
| Operating Income (Reported) | $2.4B | $2.9B | $2.9B | $2.9B | $3.1B | |
| Operating Income (Adjusted) | $2.3B | $2.9B | $3.1B | $2.8B | $3.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.8B | $4.8B | $4.8B | $5.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.8B | $3.1B | $3.1B | $3.1B | $3.4B | |
| Gross Profit | $1.6B | $1.7B | $1.7B | $1.6B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $827M | $862M | $835M | $765M | $791M | |
| Other Inc / (Exp) | -$11M | $1M | $15M | -$15M | $63M | |
| Operating Expenses | $968M | $1B | $967M | $896M | $927M | |
| Operating Income | $669M | $724M | $702M | $718M | $791M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $665M | $729M | $738M | $722M | $872M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $160M | $170M | $158M | $179M | $213M | |
| Net Income to Company | $505M | $563M | $580M | $546M | $663M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $505M | $563M | $580M | $546M | $663M | |
| Basic EPS (Cont. Ops) | $0.95 | $1.07 | $1.14 | $1.10 | $1.34 | |
| Diluted EPS (Cont. Ops) | $0.95 | $1.07 | $1.14 | $1.10 | $1.34 | |
| Weighted Average Basic Share | $530M | $524M | $509M | $497M | $494M | |
| Weighted Average Diluted Share | $531M | $525M | $509M | $498M | $495M | |
| EBITDA | $808M | $874M | $879M | $866M | $1B | |
| EBIT | $667M | $731M | $747M | $733M | $884M | |
| Revenue (Reported) | $4.4B | $4.8B | $4.8B | $4.8B | $5.1B | |
| Operating Income (Reported) | $669M | $724M | $702M | $718M | $791M | |
| Operating Income (Adjusted) | $667M | $731M | $747M | $733M | $884M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.7B | $1.8B | $2.2B | $2.6B | $2.2B | |
| Short Term Investments | $44M | $927M | $310M | $14M | $12M | |
| Accounts Receivable, Net | $3.1B | $3.6B | $3.8B | $3.8B | $4.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1B | $1.1B | $969M | $1B | $1.2B | |
| Total Current Assets | $6.9B | $7.3B | $7.3B | $7.5B | $7.5B | |
| Property Plant And Equipment | $2.3B | $2.1B | $2B | $1.7B | $1.5B | |
| Long-Term Investments | $440M | $66M | $70M | $80M | $90M | |
| Goodwill | $5B | $5.6B | $5.7B | $6.1B | $7B | |
| Other Intangibles | $1B | $1.2B | $1.2B | $1.1B | $1.6B | |
| Other Long-Term Assets | $846M | $1.1B | $1B | $1B | $1B | |
| Total Assets | $16.9B | $17.9B | $17.9B | $18.5B | $20B | |
| Accounts Payable | $389M | $361M | $360M | $337M | $340M | |
| Accrued Expenses | $409M | $462M | $387M | $387M | $418M | |
| Current Portion Of Long-Term Debt | $38M | $38M | $8M | $33M | $33M | |
| Current Portion Of Capital Lease Obligations | $211M | $195M | $174M | $153M | $152M | |
| Other Current Liabilities | $469M | $395M | $357M | $500M | $593M | |
| Total Current Liabilities | $3.5B | $3.5B | $3.3B | $3.3B | $3.6B | |
| Long-Term Debt | $663M | $626M | $638M | $606M | $875M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.1B | $5.9B | $5.5B | $5.3B | $5.6B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | |
| Other Common Equity Adj | $110M | $37M | -$299M | -$94M | -$296M | |
| Common Equity | $10.8B | $12B | $12.3B | $13.2B | $14.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $10.8B | $12B | $12.3B | $13.2B | $14.4B | |
| Total Liabilities and Equity | $16.9B | $17.9B | $17.9B | $18.5B | $20B | |
| Cash and Short Terms | $2.7B | $2.7B | $2.5B | $2.6B | $2.2B | |
| Total Debt | $701M | $664M | $646M | $639M | $908M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.2B | $2.5B | $2.2B | $2B | |
| Short Term Investments | $185M | $127M | $23M | $12M | $12M | |
| Accounts Receivable, Net | $3.2B | $3.7B | $3.7B | $3.8B | $4.2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2B | $1.1B | $1B | $996M | $1.3B | |
| Total Current Assets | $6.6B | $7.1B | $7.2B | $7.1B | $7.5B | |
| Property Plant And Equipment | $2.2B | $2.1B | $1.9B | $1.6B | $1.5B | |
| Long-Term Investments | $439M | $458M | $64M | $83M | $94M | |
| Goodwill | $5.2B | $5.6B | $6B | $6.4B | $7B | |
| Other Intangibles | $1.1B | $1.2B | $1.3B | $1.2B | $1.6B | |
| Other Long-Term Assets | $760M | $708M | $943M | $1B | $1B | |
| Total Assets | $16.7B | $17.4B | $18.1B | $18.4B | $20B | |
| Accounts Payable | $349M | $394M | $332M | $291M | $326M | |
| Accrued Expenses | $412M | $461M | $405M | $444M | $446M | |
| Current Portion Of Long-Term Debt | $38M | $38M | $16M | $33M | $33M | |
| Current Portion Of Capital Lease Obligations | $202M | $194M | $173M | $143M | $155M | |
| Other Current Liabilities | $376M | $354M | $372M | $464M | $628M | |
| Total Current Liabilities | $3.2B | $3.2B | $3.3B | $3B | $3.4B | |
| Long-Term Debt | $654M | $617M | $630M | $598M | $567M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.6B | $5.5B | $5.5B | $4.9B | $5.1B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | |
| Other Common Equity Adj | $81M | -$19M | -$222M | -$156M | -$165M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $11B | $12B | $12.7B | $13.5B | $14.9B | |
| Total Liabilities and Equity | $16.7B | $17.4B | $18.1B | $18.4B | $20B | |
| Cash and Short Terms | $2.2B | $2.3B | $2.5B | $2.2B | $2B | |
| Total Debt | $692M | $655M | $646M | $631M | $600M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.4B | $2.1B | $2.3B | $2.1B | $2.2B | |
| Depreciation & Amoritzation | $559M | $574M | $569M | $555M | $542M | |
| Stock-Based Compensation | $232M | $246M | $261M | $176M | $175M | |
| Change in Accounts Receivable | $264M | -$407M | -$238M | -$43M | -$49M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3B | $2.5B | $2.6B | $2.3B | $2.1B | |
| Capital Expenditures | $398M | $279M | $332M | $317M | $297M | |
| Cash Acquisitions | -$1.1B | -$970M | -$339M | -$409M | -$1.6B | |
| Cash From Investing | -$1.2B | -$2.2B | -$106M | -$331M | -$1.6B | |
| Dividends Paid (Ex Special Dividend) | -$480M | -$509M | -$564M | -$591M | -$600M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.7B | -- | $650M | -- | $600M | |
| Long-Term Debt Repaid | -$1.8B | -$53M | -$686M | -$25M | -$373M | |
| Repurchase of Common Stock | -$1.6B | -$771M | -$1.4B | -$1.1B | -$605M | |
| Other Financing Activities | -- | -- | -$3M | -- | -- | |
| Cash From Financing | -$2B | -$1.2B | -$1.9B | -$1.6B | -$915M | |
| Beginning Cash (CF) | $2.6B | $2.7B | $1.8B | $2.3B | $2.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $52M | -$872M | $523M | $390M | -$437M | |
| Ending Cash (CF) | $2.7B | $1.8B | $2.3B | $2.7B | $2.2B | |
| Levered Free Cash Flow | $2.9B | $2.2B | $2.2B | $2B | $1.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $505M | $563M | $580M | $546M | $663M | |
| Depreciation & Amoritzation | $141M | $143M | $132M | $133M | $136M | |
| Stock-Based Compensation | $62M | $56M | $44M | $42M | $42M | |
| Change in Accounts Receivable | -$131M | -$117M | $89M | $39M | -$177M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $181M | $306M | $729M | $95M | $400M | |
| Capital Expenditures | $88M | $120M | $98M | $79M | $77M | |
| Cash Acquisitions | -$310M | $19M | -$409M | -$421M | -- | |
| Cash From Investing | -$538M | $700M | -$215M | -$238M | -$7M | |
| Dividends Paid (Ex Special Dividend) | -$128M | -$143M | -$150M | -$151M | -$155M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$15M | -$14M | -- | -$40M | -$312M | |
| Repurchase of Common Stock | -$240M | -$474M | -$222M | -$133M | -$209M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$340M | -$600M | -$350M | -$304M | -$657M | |
| Beginning Cash (CF) | $2.7B | $1.8B | $2.3B | $2.7B | $2.2B | |
| Foreign Exchange Rate Adjustment | -$10M | -$6M | -- | -$39M | $13M | |
| Additions / Reductions | -$697M | $406M | $164M | -$447M | -$264M | |
| Ending Cash (CF) | $2B | $2.2B | $2.5B | $2.2B | $2B | |
| Levered Free Cash Flow | $93M | $186M | $631M | $16M | $323M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $2.2B | $2.3B | $2.1B | $2.4B | |
| Depreciation & Amoritzation | $564M | $576M | $558M | $556M | $545M | |
| Stock-Based Compensation | $239M | $240M | $249M | $174M | $175M | |
| Change in Accounts Receivable | $120M | -$393M | -$32M | -$93M | -$265M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3B | $2.6B | $3B | $1.7B | $2.4B | |
| Capital Expenditures | $374M | $311M | $310M | $298M | $295M | |
| Cash Acquisitions | -$1.3B | -$641M | -$767M | -$421M | -$1.2B | |
| Cash From Investing | -$1.5B | -$926M | -$1B | -$354M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$487M | -$524M | -$571M | -$592M | -$604M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.8B | -$52M | -- | -$65M | -$645M | |
| Repurchase of Common Stock | -$1.4B | -$1B | -$1.2B | -$975M | -$681M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$3.5B | -$1.5B | -$1.7B | -$1.6B | -$1.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2B | $231M | $281M | -$221M | -$254M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.6B | $2.3B | $2.7B | $1.4B | $2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $505M | $563M | $580M | $546M | $663M | |
| Depreciation & Amoritzation | $141M | $143M | $132M | $133M | $136M | |
| Stock-Based Compensation | $62M | $56M | $44M | $42M | $42M | |
| Change in Accounts Receivable | -$131M | -$117M | $89M | $39M | -$177M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $181M | $306M | $729M | $95M | $400M | |
| Capital Expenditures | $88M | $120M | $98M | $79M | $77M | |
| Cash Acquisitions | -$310M | $19M | -$409M | -$421M | -- | |
| Cash From Investing | -$538M | $700M | -$215M | -$238M | -$7M | |
| Dividends Paid (Ex Special Dividend) | -$128M | -$143M | -$150M | -$151M | -$155M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$15M | -$14M | -- | -$40M | -$312M | |
| Repurchase of Common Stock | -$240M | -$474M | -$222M | -$133M | -$209M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$340M | -$600M | -$350M | -$304M | -$657M | |
| Beginning Cash (CF) | $2.7B | $1.8B | $2.3B | $2.7B | $2.2B | |
| Foreign Exchange Rate Adjustment | -$10M | -$6M | -- | -$39M | $13M | |
| Additions / Reductions | -$697M | $406M | $164M | -$447M | -$264M | |
| Ending Cash (CF) | $2B | $2.2B | $2.5B | $2.2B | $2B | |
| Levered Free Cash Flow | $93M | $186M | $631M | $16M | $323M | |
Get CTSH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CTSH
Sector
P/E ratio
16.41x
21.61x
PEG ratio
1.16x
0.02x
P/B ratio
2.58x
2.09x
Price / LTM sales
1.93x
1.50x
Growth Metrics
CTSH
Sector
Revenue growth
7.46%
4.54%
Earnings growth
21.82%
11.58%
Revenue (5-year growth)
3.3%
6.66%
Earnings forecast
$1.20
$0.11
Profitability
CTSH
Sector
Profitability FY 2024
$6.8B
$83.9M
Return on invested capital
15.69%
0.78%
Return on assets
12.14%
-0.06%
Return on equity
16.56%
1.45%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
30
Balance Sheet
CTSH
Sector
Total cash
$2B
$55.8M
Short term investments
$12M
$18.4M
Total assets
$20B
$245M
Long term debt
$600M
$7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
52
SRPT alert for May 8
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 23.38% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
